Cbdmd, Inc. · AMEX:YCBD
Cbdmd — Investor Presentation (February 2022)
15 slides from Cbdmd's investor presentation, Feb 15, 2022
Slide 1: Purposeful Wellness – February 2022 Investor Presentation
Purposeful Wellness CbdMDeay FEB 2022 INVESTOR PRESENTATION
Slide 2: Safe Harbor Statement
SAFE HARBOR STATEMENT cbdMDax This presentation contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be ide
Slide 3: US Hemp-Derived CBD Market 2018-2026
(2018-2026) 2018 2019 + 2020 2021* 2022* 2023* 2024* 2025* 2026* Source: Brightfield Group 2021 e The US hemp-derived CBD market was estimated to be $4.7 billion in retail sales in 2021, a 7.8x fold increase from 2018 sales of $600M * Sales are expected to reach $12.0 billion by 2026, driven by acce
Slide 4: Investment Highlights
INVESTMENT HIGHLIGHTS @) IMDex Leader & innovator in CBD industry ° Patent-pending Superior Broad Spectrum Extract formula o First CBD product: NSF International's Certified for Sport® Extensive portfolio of 130+ SKUs Multi-channel media strategy with unique audience focus: © Sports & like-minded pa
Slide 5: cbdMD at a Glance
ChdMD AT A GLANCE cbdMDaw BUSINESS OVERVIEW * We supply the industry's highest-quality products deserving of your daily routine. Choose consistency, choose FOUNDED wellness, choose cbdMD. 2015 o Own and operate the nationally-recognized cbdMD, Paw CBD and cbdMD Botanicals brands (all in-house) © Est
Slide 6: Milestones
ch MILESTONES clam Bad ise Jos [rope FARM BILL CURE BASED FIRST CBO COMPANY TICKER CHANGE TO YCBD BUBBA WATSON FARM BILL 2018 TO SPONSOR A MAIR NYSE AMERICAN DEVELOPMENT FOUNDED pb PARTNERSHIP e e e e @ e 2017 2018 2018 2019 2019 2019 BF PAW CBD PRODUCT OF THE YEAR INTERNATIONAL (UK) © PRODUCTOFTHEY
Slide 7: Product Suites
PRODUCT SUITES cbdMDe»
Slide 8: Product of the Year Winners
PRODUCT OF THE YEAR WINNERS cbdMDzw @ paw cbd [Peon Bute) = © | CBD TREATS WINNER: WINNER: WINNER: WINNER: CBD Topical CBD Sleep Aid CBD Ingestible CBD Pet Survey of 40,000 Survey of 40,000 Survey of 40,000 Survey of 40,000 people by Kantar people by Kantar people by Kantar people by Kantar 8
Slide 9: TV Advertising
TV ADVERTISING cbdMDew Feel Like This? Reach for cbdMD cbdMD Freeze Our award-winning topical is a go-to favorite among consumers. With select ingredients designed to complement the power of CBD, our topicals can be used as a daily tool for recovery and pain relief. Broadcasted on numerous connected
Slide 10: Product Innovation Continues to Drive Growth
PRODUCT INNOVATION cbdMDex CONTINUES TO DRIVE GROWTH PRODUCT EXTENSIONS SLEEP-AID LINE EXTENSION Launched Q4 FY2021 GUMMY LINE EXTENSION Launched QI FY2022 ANXIETY LINE EXTENSION Launch Q2 FY2022 Devote resources to ongoing R&D processes to expand product offering to meet evolving consumer demand *
Slide 11: E-commerce Sales Account for 76% of Net Sales
i aml E-COMMERCE SALES ACCOUNT FOR 76% OF OVERALL NET SALES* E-commerce | cbdMD.com 716% Wholesale & Retail 24% “Fiscal Quarter ended December 31, 2021 "
Slide 12: Total Net Sales
ee ene ~aaal TOTAL NET SALES FISCAL YEAR FISCAL YEAR FISCAL YEAR 3 YEAR FISCAL 3 YEAR CALENDAR ENDED ENDED ENDED CUMULATIVE CUMULATIVE 2019 2020 2021 2019-2021 2019-2021 12
Slide 13: Balance Sheet – December 31, 2021
cbdMDas All figures show in millions, US$ December 31, 2021 CASH WORKING CAPITAL TOTAL ASSETS TOTAL LIABILITIES * SHAREHOLDER'S EQUITY * includes $3,501,000 non-cash contingent liability related to earn-out rights.
Slide 14: Key Metrics and Share Ownership
KEY METRICS ‘Common Stock YCBD 8.0% Series Cumulative Convertible Preferred Stock YCBDpA Exchange NYSE American Recent Common Price! $1.08 Recent Preferred Price! $6.10 ‘Common Shares ‘Outstanding’? 58,277,970 Preferred Shares Outstanding! 5,000,000 Market Cap! $63.0M FY End Sept. 30 as of 12/51/202
Slide 15: Investor Relations
—— am INVESTOR RELATIONS: John Weston john.weston@cbdMD.com 704-445-3060 ext. 1103